Company type | Subsidiary |
---|---|
Industry | |
Founded | March 1996 |
Headquarters | Sunnyvale, California, U.S. |
Key people |
|
Revenue | US$531.08 million (August 2016) |
Number of employees | 6,000+ (2024) |
Parent | Danaher Corporation[1] |
Website | cepheid |
Footnotes / references [2][3] |
Cepheid[a] is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA). The tests can be used to identify and analyze pathogens and genetic disorders. Cepheid sells clinical tests for healthcare-associated infections, infectious diseases, sexual health, oncology and genetics.[5]
The cartridges used in Cepheid's testing machines are single-use and must be bought from the manufacturer. The company has been accused of profiteering, particularly in developing countries, by pricing the cartridges at many times the cost of production, and engaging in price discrimination.[citation needed]
2013 CEO
was invoked but never defined (see the help page).
Cite error: There are <ref group=lower-alpha>
tags or {{efn}}
templates on this page, but the references will not show without a {{reflist|group=lower-alpha}}
template or {{notelist}}
template (see the help page).